Profile picture

Doctor Daniel Peter Andersson

Karolinska Institute, Stockholm (Sweden)
Follow
Logo ESC

Contributor content

Association between treatment with phosphodiesterase-5 inhibitors, versus alprostadil and survival in patients with coronary artery disease
Presentation
Association between treatment with phosphodiesterase-5 inhibitors, versus alprostadil and survival in patients with coronary artery disease
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources